Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17520245 | 0.98 | LMNA (0.63) | ALDH1A1LMNATSHREPHX2RECQL | |
| SCHEMBL27948186 | 0.94 | TSHR (0.58) | ALDH1A1LMNATSHREPHX2TBXAS1 | |
| SCHEMBL6763939 | 0.91 | KMT2A (0.53) | ALDH1A1LMNAALOX15KMT2A | |
| SCHEMBL6763941 | 0.91 | KMT2A (0.53) | ALDH1A1LMNAALOX15KMT2A | |
| SCHEMBL10890107 | 0.88 | ALDH1A1 (0.53) | ALDH1A1LMNATSHREPHX2RECQL | |
| SCHEMBL10889301 | 0.88 | ALDH1A1 (0.53) | ALDH1A1LMNATSHREPHX2RECQL | |
| SCHEMBL10892227 | 0.88 | ALDH1A1 (0.53) | ALDH1A1LMNATSHREPHX2RECQL | |
| SCHEMBL1360794 | 0.85 | ALDH1A1 (0.49) | ALDH1A1LMNATSHREPHX2RECQL | |
| SCHEMBL493731 | 0.85 | TSHR (0.55) | ALDH1A1LMNATSHRALOX15KDM4E | |
| SCHEMBL10887765 | 0.82 | ALDH1A1 (0.50) | ALDH1A1LMNATSHREPHX2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | claimed |
| EP-2723841-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2017-01-04 | — | — | EP | claimed |
| US-20160186093-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-06-30 | — | — | US | claimed |
| US-9309487-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-12 | — | — | US | claimed |
| US-20140378360-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2014-12-25 | — | — | US | claimed |
| EP-2723841-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2014-04-30 | — | — | EP | claimed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | claimed |
| WO-2012177357-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2012-12-27 | — | — | WO | claimed |
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | disclosed |
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | disclosed |
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | disclosed |
| US-9822327-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| US-9822327-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| US-9822327-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | disclosed |
| WO-2012177357-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2012-12-27 | — | — | WO | disclosed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | disclosed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | disclosed |
| US-7091357-B2 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2006-08-15 | — | — | US | disclosed |
| US-20030225142-A1 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225142-A1 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | CHRNA4, CHRNA2, CHRNA5 | ALDH1A1 923/4885LMNA 3674/4885TSHR 340/4885 |
| US-20180037843-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALDH1A1 1292/4885LMNA 2632/4885TSHR 4787/4885 |
| US-20120329696-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALDH1A1 1292/4885LMNA 2632/4885TSHR 4787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.